OR WAIT null SECS
February 06, 2020
Energy and water waste can be improved with new technologies, and sustainability can be considered in the design of new facilities.
January 27, 2020
Bioassays are critical for assessing potency and biological activity during biopharmaceutical activity, but they must be carefully designed to ensure reliability. Learn about new developments in cell-based bioassays and binding assays.
January 22, 2020
A review of the market dynamics and drug development trends driving strategic outsourcing decisions.
January 20, 2020
Mahesh Kumar shares background, insights, and results of a study in which a relevant sensitivity and low positive control value in immunogenicity assays are identified.
Study focused on demonstrating the effect of freeze-thaw of conjugated critical reagents on the binding capacity in immunogenicity assay performance.
This paper answers a major concern of manufacturers: Do x-rays affect the quality and efficacy of a drug during product inspection?
This paper describes the existing regulatory framework for combined products and focuses on stability testing to assess drug or biological-device compatibility.
January 16, 2020
January 13, 2020
A core challenge among drug developers is working with challenging APIs, which are increasingly becoming more hydrophobic and/or with stronger crystal lattice structures, each ultimately poorly water soluble. This ebook covers a variety of important tools for formulators.
December 19, 2019
* Differentiate the suitability, quality and processability of an excipient. * Recognize the significant impact of superior excipient processability. * Understand the economic return associated with excipient selection.